A comprehensive evaluation of the immune system response and type-I Interferon signaling pathway in hospitalized COVID-19 patients MS Soltani-Zangbar, F Parhizkar, E Ghaedi, A Tarbiat, R Motavalli, ... Cell Communication and Signaling 20 (1), 106, 2022 | 23 | 2022 |
Expression level of immune checkpoint inhibitory factors in preeclampsia S Madadi, S Mohammadinejad, A Alizadegan, M Hojjat-Farsangi, S Dolati, ... Human Immunology 83 (8-9), 628-636, 2022 | 9 | 2022 |
Application of cell free DNA in ART A Alizadegan, H Dianat-Moghadam, N Shadman, M Nouri, K Hamdi, ... Placenta 120, 18-24, 2022 | 6 | 2022 |
Sirolimus‐and cyclosporine‐loaded nanostructured lipid carriers: Development, characterization, and in vitro evaluation in T‐cell profiles of patients with a history of … F Parhizkar, M Yousefi, MS Soltani‐Zangbar, Z Parhizkar, ... Reproductive Medicine and Biology 22 (1), e12509, 2023 | 1 | 2023 |
Serum IFN-α autoantibodies and immune cell dysregulation are linked to COVID-19 severity MS Soltani-Zangbar, F Parhizkar, E Ghaedi, A Tarbiat, R Motavalli, ... | | 2023 |
Isolation of cfDNA from spent culture media and its association with implantation rate and maternal immunomodulation A Alizadegan, M Akbarzadeh, MS Soltani-Zangbar, R Sambrani, K Hamdi, ... BMC Research Notes 15 (1), 259, 2022 | | 2022 |